Ischemic cardiac disease(effort angina pectoris,asymptomatic myocardial ischemia,acute coronary syndrome
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients meeting all of the following conditions will be included: 1) underwent coronary bypass grafting using the vein graft 2) between 20 and 85 years old 3) written consent for participation in the study
Exclusion criteria
Exclusion criteria: Patients meeting one of the following conditions will be excluded: 1) severe liver dysfunction 2) renal dysfunction (Cre>= 2.0mg/dL) 3) severe heart failure (NYHA/New York Heart Association stage III or severer) 4) malignancies or other diseases with poor prognosis 5) pregnant, lactating, and possibly pregnant women and those planning to become pregnant 6) judged as ineligible by clinical investigators
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The patency of saphenous vein graft one year after CABG | — |
Secondary
| Measure | Time frame |
|---|---|
| 1) Lumen area, intimal thickening and incidence of thrombus evaluated by OCT 2) Coronary flow velocity of saphenous vein graft 3) Value of inflammatory and vasoactive biomarker | — |
Countries
Japan
Contacts
Kobe University Graduate School of Medicine Division of Cardiovascular Medicine